This may be due to HS‐induced leptin resistance through the stimulation of endogenous fructose production via the aldose reductase (polyol) pathway, contributing to dyslipidemia by altering lipid metabolism (Lanaspa et al., 2018; Sanchez‐Lozada et al., 2019). This evidence concerns the gene AKR1B1 and metabolic syndrome.